NCT02075242View on ClinicalTrials.gov

TO Compare the Triple Drug Therapy and Dual Therapy .

PHASE4UnknownINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
HEPATITIS
Interventions
DRUG

Mycophenolate Mofetil

experimental group receive Tacrolimus as a main immunosuppressants and assistant is My-rept capsule®(Mycophenolate Mofetil),

DRUG

Tacrolimus

control group receive same immunosuppressants except for My-rept capsule®(Mycophenolate Mofetil- investigational product

Trial Locations (1)

Unknown

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER